Plasma Levels of Platelet Factor 4 Measured by Radioimmunoassay
Article first published online: 7 JUL 2008
British Journal of Haematology
Volume 40, Issue 3, pages 489–500, November 1978
How to Cite
Chesterman, C. N., McGready, J. R., Doyle, D. J. and Morgan, F. J. (1978), Plasma Levels of Platelet Factor 4 Measured by Radioimmunoassay. British Journal of Haematology, 40: 489–500. doi: 10.1111/j.1365-2141.1978.tb05819.x
- Issue published online: 7 JUL 2008
- Article first published online: 7 JUL 2008
- (Accepted for publication 10 April 1978)
Summary. A radioimmunoassay has been developed to measure platelet factor 4 (PF4) in biological fluids both in vitro and in vivo. The assay has been shown to be highly specific for PF4 and has a sensitivity of 0.08 ng/assay tube and 1.6 ng/ml of plasma. The preparation of plasma for the measurement of in vivo levels of PF4 requires the use of an anticoagulant containing EDTA, theophylline and prostaglandin E1, the immediate cooling of the blood and high speed or prolonged centrifugation to reduce platelet contamination. Plasma levels of PF4 are normally between 4 and 24 ng/ml with a median of 7.4 ng/ml.
Plasma PF4 levels are markedly increased during cardiopulmonary bypass surgery with shortened 51Cr-labelled platelet survival times and during arterial thrombosis. However, despite similarly shortened platelet survival times, the level of PF4 is normal in immune thrombocytopenia. Elevations of plasma PF4 levels are found following surgery, acute myocardial infarction and frequently during acute infections and in inflammatory states. On the contrary, normal levels are usual in disseminated malignancy, in severe hepatic and renal disease and in chronic arterial disease.
The measurement of PF4 is a useful addition to the study of platelet pathophysiology. It is apparent, however, that raised levels are by no means specific for thromboembolic disease and similarly platelet destruction is not invariably associated with abnormally increased plasma PF4 levels.